Fragment Pharma, Inc.
纳米技术研究
La Jolla,CA 9 位关注者
Applying Nanotechnology to Enhance Cannabinoid Usage, Efficacy, and Commercialization
关于我们
FRAGMENT is a biotechnology and consumer product development company specializing in high-intensity industrial scale ultrasonic technology to create commercial use nanoemulsions and nanocrystals. FRAGMENT’s focus is developing and distributing “water soluble” cannabinoid consumer products suitable for beverage, cosmetic, food, and pharmaceutical applications, both privately and white-label. FRAGMENT represents the next generation of cannabinoid processing. FRAGMENT uses patented industrial scale expandable ultrasonic processors with standard SOP’s and GRAS (natural) ingredients with a goal of becoming cGMP.
- 所属行业
- 纳米技术研究
- 规模
- 2-10 人
- 总部
- La Jolla,CA
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Cannabinoid nanoemulsification、Nanotization、Nanoemulsion、Key Performance Indicators、Branding、Product Development、Marketing、Distribution、Project Management、Distillation、Creativity、Compliance、Laboratory、Policies & Procedures、Chemistry、Science、Finance、Human Resources、Team Building和Mergers & Acqusitions
地点
-
主要
US,CA,La Jolla,92037